...
首页> 外文期刊>Investigative radiology >Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy.
【24h】

Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy.

机译:通过电感耦合等离子体质谱法比较G(DTPA-BMA)(Omniscan)与G(HP-DO3A)(ProHance)相对于g在人骨组织中的保留。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The objective of this study was to determine the gadolinium (Gd) concentration remaining in human bone tissue after administration of standard clinical doses of 2 Gd-based contrast agents: ProHance and Omniscan. MATERIALS AND METHODS: After administration of 0.1 mmol/kg of Gd chelate to patients undergoing hip replacement surgery, bone specimens were collected and analyzed, and compared with an age-matched control population without a history of Gd chelate administration. Bone specimens were collected fresh, refrigerated, and subsequently frozen. After grinding and freeze-drying, tissue digestion was performed using Teflon bombs and concentrated nitric acid. A method for analysis of Gd in bone specimens was developed and validated using inductively coupled plasma mass spectroscopy (ICP-MS). RESULTS: Results were compared with a previous study using a different technique for analysis of the same tissue specimens. Tissue retention was 1.77+/-0.704 microg Gd/g bone (n=9) for Omniscan and 0.477+/-0.271 microg Gd/g bone (n=10) for ProHance measured by ICP-MS. These findings confirmed results from the previous ICP-AES study. CONCLUSION: Omniscan (Gd[DTPA-BMA]) left approximately 4 times (previous study 2.5 times) more Gd behind in bone than did ProHance (Gd[HP-DO3A]).
机译:目的:本研究的目的是确定在服用标准临床剂量的两种基于Gd的造影剂ProHance和Omniscan后,人体骨组织中残留的G(Gd)浓度。材料与方法:在对接受髋关节置换手术的患者施用0.1 mmol / kg的Gd螯合物后,收集并分析骨标本,并与没有Gd螯合史的年龄匹配对照组进行比较。新鲜,冷冻并随后冷冻收集骨标本。研磨并冷冻干燥后,使用特富龙炸弹和浓硝酸进行组织消化。开发了一种分析骨标本中Gd的方法,并使用电感耦合等离子体质谱(ICP-MS)进行了验证。结果:将结果与先前的研究进行了比较,使用不同的技术对相同的组织样本进行了分析。通过ICP-MS测量,Omniscan的组织保留为1.77 +/- 0.704 microg Gd / g骨骼(n = 9),ProHance的组织保留为0.477 +/- 0.271 microg Gd / g骨骼(n = 10)。这些发现证实了以前的ICP-AES研究的结果。结论:与ProHance(Gd [HP-DO3A])相比,Omniscan(Gd [DTPA-BMA])在骨骼中残留的Gd大约多4倍(以前的研究是2.5倍)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号